UiPath Inc (NYSE:PATH) reported better-than-expected financial results for the fourth quarter of fiscal 2026 after the market close on Wednesday.

The company reported revenue of $481.11 million versus estimates of $464.49 million and adjusted earnings per share of 30 cents versus estimates of 26 cents, per Benzinga Pro.

“As enterprise AI adoption moves from experimentation to scaled deployment, customers increasingly need a platform that can execute complex processes with reliability, governance, and scale,” said Daniel Dines, founder and CEO of UiPath.

UiPath expects first-quarter revenue to be between $395 million and $400 million versus estimates of $394.03 million. The company expects fiscal 2027 revenue to be in the range of $1.754 billion to $1.759 billion versus estimates of $1.744 billion.

UiPath shares fell 6.3% to trade at $11.60 on Thursday.

These analysts made changes to their price targets on UiPath following earnings announcement.

  • Morgan Stanley analyst Sanjit Singh maintained UiPath with an Equal-Weight rating and lowered the price target from $19 to $17.
  • Mizuho analyst Siti Panigrahi maintained the stock with a Neutral and lowered the price target from $15 to $12.
  • Wells Fargo analyst Michael Turrin maintained UiPath with an Equal-Weight rating and lowered the price target from $14 to $13.
  • DA Davidson analyst Lucky Schreiner maintained the stock with a Neutral and lowered the price target from $15 to $13.
  • B of A Securities analyst Brad Sills maintained UiPath with an Underperform rating and cut the price target from $14 to $12.
  • TD Cowen analyst Bryan C. Bergin maintained the stock with a Hold and lowered the price target from $16 to $13.
  • Truist Securities analyst Terry Tillman maintained UiPath with a Hold and lowered the price target from $17 to $12.
  • Canaccord Genuity analyst Kingsley Crane maintained the stock with a Buy and lowered the price target from $19 to $15.

Considering buying PATH stock? Here’s what analysts think:

Photo via Shutterstock